Abstract

BD analytics (BDA) has been steadily garnering interest among academicians and users, considering its advantages, drawbacks, and anticipated outcomes. This study investigates the determinants of BDA adoption regarding the impact of BDA adoption on corporate entrepreneurship. Data on pharmaceutical industry corporations were obtained from 219 responses to a questionnaire. SPSS 29 and AMOS 29 were used to analyze data. The findings show that relative advantages, security concerns, top management support, organizational readiness, competitive pressures, and partner pressures positively influence BDA adoption. The results also reveal a positive impact of BDA on corporate entrepreneurship. The results of this study can contribute to practitioners becoming competent in diagnosing the essential factors that inspire or impede corporations in adopting BDA applications. Moreover, this study may offer valuable managerial insights for policymakers to enhance corporate entrepreneurship by efficiently exploiting BDA capabilities.